PHARMACEUTICAL PRODUCTS DIETETIC

Brand Owner (click to sort) Address Description
INBIOTYS BIOCODEX 7 avenue Gallieni F-94250 GENTILLY France Pharmaceutical products for dietetic and dermatological use; food supplements and nutritional supplements; vitamin-based preparations; preparations based on minerals and/or trace elements for human beings for medical purposes; dietetic foodstuffs used as supplements to a normal diet adapted for medical use; dietetic beverages for medical use; none of the foregoing intended to detect or treat allergic diseases;Medical apparatus and devices for administering pharmaceutical products, food supplements, nutritional supplements and preparations based on minerals and/or trace elements; medical apparatus and devices for administering dietetic foodstuffs and dietetic beverages for medical use; medical apparatus and devices for applying dermatological preparations;
SYMBIOSYS BIOCODEX 7 avenue Gallieni F-94250 GENTILLY France Pharmaceutical products for dietetic and dermatological use; food supplements and nutritional supplements; vitamin-based preparations; preparations based on minerals and/or trace elements for human beings for medical purposes; pharmaceutical preparations for skin care; dermatological preparations for medical use; dietetic foodstuffs used as supplements to a normal diet adapted for medical use; dietetic beverages for medical use;Medical apparatus and devices for administering pharmaceutical products, food supplements, nutritional supplements and preparations based on minerals and/or trace elements; medical apparatus and devices for administering dietetic foodstuffs and dietetic beverages for medical use; medical apparatus and devices for applying dermatological preparations;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. This invention relates to the regulation of vascular endothelium biocompatibility and to the inhibition of vessel wall cell and other types of cell hyperplasia following vessel wall dysfunction and/or injury. More particularly, the invention relates to the dietetic and pharmaceutical preparations of 13-hydroxyoctadeca-9Z, 11E-dienoic acid (13-HODE) and its use in reducing or inhibiting vessel wall hyperlasia and restoring vessel wall biocompatibility.